TISSUE ENGINEERING OF VALVED VENOUS CONDUITS (VVC) VERSUS CONSERVATIVE THERAPY IN PATIENTS WITH CHRONIC VENOUS INSUFFICIENCY (CVI). A DECISION ANALYTIC MODEL USING EXPERT ESTIMATED UTILITIES BASED ON DERIVED DATA FROM ANIMAL STUDIES AS A PRE-MARKETING TECHNOLOGY ASSESSMENT APPROACH WITH GERMAN DATA

Dintsios CM, Hagen A, Gerhardus A, Krauth C (2008)
VALUE IN HEALTH 11(6): A406-A406.

Download
Es wurde kein Volltext hochgeladen. Nur Publikationsnachweis!
Kurzbeitrag Konferenz | Veröffentlicht | Englisch
Autor
; ; ;
Erscheinungsjahr
Band
11
Zeitschriftennummer
6
Seite
A406-A406
ISSN
PUB-ID

Zitieren

Dintsios CM, Hagen A, Gerhardus A, Krauth C. TISSUE ENGINEERING OF VALVED VENOUS CONDUITS (VVC) VERSUS CONSERVATIVE THERAPY IN PATIENTS WITH CHRONIC VENOUS INSUFFICIENCY (CVI). A DECISION ANALYTIC MODEL USING EXPERT ESTIMATED UTILITIES BASED ON DERIVED DATA FROM ANIMAL STUDIES AS A PRE-MARKETING TECHNOLOGY ASSESSMENT APPROACH WITH GERMAN DATA. VALUE IN HEALTH. 2008;11(6):A406-A406.
Dintsios, C. M., Hagen, A., Gerhardus, A., & Krauth, C. (2008). TISSUE ENGINEERING OF VALVED VENOUS CONDUITS (VVC) VERSUS CONSERVATIVE THERAPY IN PATIENTS WITH CHRONIC VENOUS INSUFFICIENCY (CVI). A DECISION ANALYTIC MODEL USING EXPERT ESTIMATED UTILITIES BASED ON DERIVED DATA FROM ANIMAL STUDIES AS A PRE-MARKETING TECHNOLOGY ASSESSMENT APPROACH WITH GERMAN DATA. VALUE IN HEALTH, 11(6), A406-A406. doi:10.1016/S1098-3015(10)66378-4
Dintsios, C. M., Hagen, A., Gerhardus, A., and Krauth, C. (2008). TISSUE ENGINEERING OF VALVED VENOUS CONDUITS (VVC) VERSUS CONSERVATIVE THERAPY IN PATIENTS WITH CHRONIC VENOUS INSUFFICIENCY (CVI). A DECISION ANALYTIC MODEL USING EXPERT ESTIMATED UTILITIES BASED ON DERIVED DATA FROM ANIMAL STUDIES AS A PRE-MARKETING TECHNOLOGY ASSESSMENT APPROACH WITH GERMAN DATA. VALUE IN HEALTH 11, A406-A406.
Dintsios, C.M., et al., 2008. TISSUE ENGINEERING OF VALVED VENOUS CONDUITS (VVC) VERSUS CONSERVATIVE THERAPY IN PATIENTS WITH CHRONIC VENOUS INSUFFICIENCY (CVI). A DECISION ANALYTIC MODEL USING EXPERT ESTIMATED UTILITIES BASED ON DERIVED DATA FROM ANIMAL STUDIES AS A PRE-MARKETING TECHNOLOGY ASSESSMENT APPROACH WITH GERMAN DATA. VALUE IN HEALTH, 11(6), p A406-A406.
C.M. Dintsios, et al., “TISSUE ENGINEERING OF VALVED VENOUS CONDUITS (VVC) VERSUS CONSERVATIVE THERAPY IN PATIENTS WITH CHRONIC VENOUS INSUFFICIENCY (CVI). A DECISION ANALYTIC MODEL USING EXPERT ESTIMATED UTILITIES BASED ON DERIVED DATA FROM ANIMAL STUDIES AS A PRE-MARKETING TECHNOLOGY ASSESSMENT APPROACH WITH GERMAN DATA”, VALUE IN HEALTH, vol. 11, 2008, pp. A406-A406.
Dintsios, C.M., Hagen, A., Gerhardus, A., Krauth, C.: TISSUE ENGINEERING OF VALVED VENOUS CONDUITS (VVC) VERSUS CONSERVATIVE THERAPY IN PATIENTS WITH CHRONIC VENOUS INSUFFICIENCY (CVI). A DECISION ANALYTIC MODEL USING EXPERT ESTIMATED UTILITIES BASED ON DERIVED DATA FROM ANIMAL STUDIES AS A PRE-MARKETING TECHNOLOGY ASSESSMENT APPROACH WITH GERMAN DATA. VALUE IN HEALTH. 11, A406-A406 (2008).
Dintsios, C. M., Hagen, A., Gerhardus, Ansgar, and Krauth, C. “TISSUE ENGINEERING OF VALVED VENOUS CONDUITS (VVC) VERSUS CONSERVATIVE THERAPY IN PATIENTS WITH CHRONIC VENOUS INSUFFICIENCY (CVI). A DECISION ANALYTIC MODEL USING EXPERT ESTIMATED UTILITIES BASED ON DERIVED DATA FROM ANIMAL STUDIES AS A PRE-MARKETING TECHNOLOGY ASSESSMENT APPROACH WITH GERMAN DATA”. VALUE IN HEALTH 11.6 (2008): A406-A406.